Apricus Biosciences Inc.

Company Website

11975 El Camino Real Ste., 300
San Diego, CA 92130

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Apricus Biosciences Inc.

Market Cap as of 6/12/2015


Market Cap as of 7/03/2014


Market Cap as of 07/02/2013


Market Cap as of 06/26/2012


Market Cap as of 01/04/2012


Market Cap as of 06/20/2011


Market Cap as of 01/06/2011


Exchange and Ticker Symbol

Nasdaq: APRI

Fields of Research

Engages in the research and development of pharmaceutical drugs and drug candidates based on its proprietary NexACT drug delivery technology

Major Products

Vitaros, Totect, NitroMist, Granisol, Aquoral, MycoVa, PrevOnco, RayVa, Nupen


Company Trade Data

Stock Symbol Close Change Volume 52-Week
Chg %Chg High Low
- 1.90%


Bassam Damaj

  • Chairman
  • Chief Executive Officer
  • President

Related News


Apricus Bio appoints Barbara Troupin as CMO

Apricus Biosciences Inc. (Nasdaq: APRI), a biopharmaceutical company advancing medicines in urology and rheumatology, announced the appointment of Barbara Troupin, M.D., as the company's chief medical officer.

Taglich Brothers initiates coverage of Apricus

Taglich Bros. Inc., a brokerage firm specializing in microcap publicly traded securities, initiated coverage of San Diego-based Apricus Biosciences Inc.